The Subject Expert Committee (SEC - Oncology) under the Central Drugs Standard Control Organization (CDSCO) has requested ...
Bristol Myers Squibb <a href=" target="_blank">(BMY.N) said on Monday that its current drug pipeline has the ability to replace up to $25 billion a year in lost revenue from patent expirations by the ...
Bristol Myers Squibb Co said on Monday it would buy MyoKardia Inc for about $13 billion to bolster its portfolio of heart disease treatments, ahead of the potential loss of sales exclusivity of some ...
"This is what I had to do. My mother gave me my grandmother's silver, and I cashed it in to pay for my medical bills," ...
Bristol Myers gains FDA Fast Track status for its Alzheimer's antibody BMS-986446 as Cobenfy drives early sales and pipeline ...
Labroots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science ...
Low-dose nivolumab (Opdivo) plus lenalidomide (Revlimid) yielded a promising response with a favorable safety profile in patients with classical Hodgkin lymphoma (cHL), according to a single-arm phase ...
A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback